Tierens A, Arad-Cohen N, Cheuk D, De Moerloose B, et al. Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease. J Clin Oncol 2024;42:2174-2185.
PMID: 38603646